» Articles » PMID: 30607158

MiR-195/miR-497 Regulate Expression of Immune Regulatory Ligands in Triple-Negative Breast Cancer

Overview
Journal J Breast Cancer
Date 2019 Jan 5
PMID 30607158
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Immune suppression is common in patients with advanced breast cancer but the mechanisms underlying this phenomenon have not been sufficiently studied. In this study, we aimed to identify B7 family members that were able to predict the immune status of patients, and which may serve as potential targets for the treatment of breast cancer. We also aimed to identify microRNAs that may regulate the expression of B7 family members.

Methods: The Cancer Genome Atlas data from 1,092 patients with breast cancer, including gene expression, microRNA expression and survival data, were used for statistical and survival analyses. Polymerase chain reaction and Western blot were used to measure messenger RNA and protein expression, respectively. Luciferase assay was used to investigate direct microRNA target.

Results: Bioinformatic analysis predicted that microRNA (miR)-93, miR-195, miR-497, and miR-340 are potential regulators of the immune evasion of breast cancer cells, and that they exert this function by targeting , , and . We chose for further investigations. We found that miR-195, miR-497, and expression levels were inversely correlated in MDA-MB-231 cells, and miR-195 and miR-497 expressions mimic inhibited expression . Mechanistic investigations demonstrated that miR-195 and miR-497 directly target 3' untranslated region.

Conclusion: Our data indicated that the level of B7 family members can predict the prognosis of breast cancer patients, and miR-195/miR-497 regulate expression in triple negative breast cancer. This regulation may further influence tumor progression and the immune tolerance mechanism in breast cancer and may be able to predict the effect of immunotherapy on patients.

Citing Articles

PD-1/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies.

Jin M, Fang J, Peng J, Wang X, Xing P, Jia K Mol Cancer. 2024; 23(1):266.

PMID: 39614285 PMC: 11605969. DOI: 10.1186/s12943-024-02176-8.


Epigenetic modification in radiotherapy and immunotherapy for cancers.

Hung S, Lee M, Chiou W, Liu D, Yu C, Chen L Tzu Chi Med J. 2024; 36(4):396-406.

PMID: 39421493 PMC: 11483092. DOI: 10.4103/tcmj.tcmj_3_24.


Mapping the function of MicroRNAs as a critical regulator of tumor-immune cell communication in breast cancer and potential treatment strategies.

Abdul Manap A, Wisham A, Wong F, Ahmad Najmi H, Ng Z, Diba R Front Cell Dev Biol. 2024; 12:1390704.

PMID: 38726321 PMC: 11079208. DOI: 10.3389/fcell.2024.1390704.


Novel microRNAs modulating ecto-5'-nucleotidase expression.

Kordass T, Chao T, Osen W, Eichmuller S Front Immunol. 2023; 14:1199374.

PMID: 37409119 PMC: 10318900. DOI: 10.3389/fimmu.2023.1199374.


Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients.

Kumar S, Chatterjee M, Ghosh P, Ganguly K, Basu M, Ghosh M Genes Dis. 2023; 10(4):1318-1350.

PMID: 37397537 PMC: 10311058. DOI: 10.1016/j.gendis.2022.07.024.


References
1.
Zou W, Chen L . Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol. 2008; 8(6):467-77. DOI: 10.1038/nri2326. View

2.
Xu H, Cheung I, Guo H, Cheung N . MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. Cancer Res. 2009; 69(15):6275-81. PMC: 2719680. DOI: 10.1158/0008-5472.CAN-08-4517. View

3.
Robinson M, McCarthy D, Smyth G . edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009; 26(1):139-40. PMC: 2796818. DOI: 10.1093/bioinformatics/btp616. View

4.
Arigami T, Narita N, Mizuno R, Nguyen L, Ye X, Chung A . B7-h3 ligand expression by primary breast cancer and associated with regional nodal metastasis. Ann Surg. 2010; 252(6):1044-51. DOI: 10.1097/SLA.0b013e3181f1939d. View

5.
Wu L, Chen Z, Zhang J, Xing Y . Effect of miR-513a-5p on etoposide-stimulating B7-H1 expression in retinoblastoma cells. J Huazhong Univ Sci Technolog Med Sci. 2012; 32(4):601-606. DOI: 10.1007/s11596-012-1004-8. View